pyridoxal has been researched along with Asymmetric Diabetic Proximal Motor Neuropathy in 3 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "We examined the ability of a pyridoxal-aminoguanidine adduct with both antiglycation and antioxidant activities in vitro to protect against neuropathy and cataract in streptozotocin-diabetic rats and compared the result with that of aminoguanidine." | 7.72 | Pyridoxal-aminoguanidine adduct is more effective than aminoguanidine in preventing neuropathy and cataract in diabetic rats. ( Chen, AS; Kamei, A; Miwa, I; Sugiura, M; Taguchi, T; Wakasugi, Y; Wang, MW, 2004) |
| "Serum pyridoxal concentrations were estimated in 13 patients who had both diabetes and carpal tunnel syndrome." | 7.66 | Carpal tunnel syndrome, diabetes and pyridoxal. ( Davis, RE; McCann, VJ, 1978) |
| "We examined the ability of a pyridoxal-aminoguanidine adduct with both antiglycation and antioxidant activities in vitro to protect against neuropathy and cataract in streptozotocin-diabetic rats and compared the result with that of aminoguanidine." | 3.72 | Pyridoxal-aminoguanidine adduct is more effective than aminoguanidine in preventing neuropathy and cataract in diabetic rats. ( Chen, AS; Kamei, A; Miwa, I; Sugiura, M; Taguchi, T; Wakasugi, Y; Wang, MW, 2004) |
| "Serum pyridoxal concentrations were estimated in 13 patients who had both diabetes and carpal tunnel syndrome." | 3.66 | Carpal tunnel syndrome, diabetes and pyridoxal. ( Davis, RE; McCann, VJ, 1978) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, AS | 1 |
| Taguchi, T | 1 |
| Sugiura, M | 1 |
| Wakasugi, Y | 1 |
| Kamei, A | 1 |
| Wang, MW | 1 |
| Miwa, I | 1 |
| McCann, VJ | 2 |
| Davis, RE | 2 |
3 other studies available for pyridoxal and Asymmetric Diabetic Proximal Motor Neuropathy
| Article | Year |
|---|---|
Pyridoxal-aminoguanidine adduct is more effective than aminoguanidine in preventing neuropathy and cataract in diabetic rats.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Cataract; Deoxyguanosine; Diabetes Mellitus, Experimental; Dia | 2004 |
Serum pyridoxal concentrations in patients with diabetic neuropathy.
Topics: Adolescent; Adult; Aged; Autonomic Nervous System; Diabetes Mellitus; Diabetic Neuropathies; Female; | 1978 |
Carpal tunnel syndrome, diabetes and pyridoxal.
Topics: Adult; Aged; Carpal Tunnel Syndrome; Diabetes Complications; Diabetes Mellitus; Diabetic Neuropathie | 1978 |